|
In vitro activity of Isavuconazole against 1488 Aspergillus isolates - a pooled analysis of nine studies (click for details) |
|
|
|
Investigation for azole resistance mediating Aspergillus
fumigatus cyp51A gene mutations using improved PCR
assays and consecutive DNA sequence analysis in clinical
samples of immunocompromised patients (click for details) |
|
|
|
Evaluation of invasive fusariosis in haematological
patients: a 10-year retrospective study (click for details) |
|
|
|
Activity of posaconazole in invasive fungal infections
associated with a variety of moulds and yeasts (click for details) |
|
|
|
Aetiologies of prolonged cough in Thai adults: the roles of
Bordetella pertussis and atypical pathogens (click for details) |
|
|
|
Emergence in vivo of Aspergillus terreus with reduced
azole susceptibility and a CYP51A M220I alteration in a
cystic fibrosis patient (click for details) |
|
|
|
Central nervous system aspergillosis in Saint Petersburg,
Russia (click for details) |
|
|
|
Invasive aspergillosis: evaluation of several diagnosis tests (click for details) |
|
|
|
Posaconazole concentrates within the endoplasmic
reticulum of host and fungal cells (click for details) |
|
|
|
Considering pharmacodynamic effects in
antifungal treatment strategies
O305 Exposure-response relationships of voriconazole in
combination with anidulafungin in a non-neutropenic
murine model of resistant Aspergillus fumigatus infection (click for details) |
|
|
